Key result
Satisfaction rates were high and comparable between Parkinson's disease patients using rechargeable (88.0%) and non-rechargeable (85.7%) deep brain stimulation batteries.
Why the study?
Deep brain stimulation offers a choice between fixed-life and rechargeable implantable pulse generators, each having advantages and disadvantages, but patient preference and satisfaction in Chinese Parkinson's disease patients had not been evaluated.
Cross-Sectional (n=220)
No
Absolute Event Rate: 88% vs 85.7%
p-value: p=0.969
Most Parkinson's disease patients are satisfied with their choice of DBS IPG, with financial status and remote programming capabilities being the primary drivers of their selection.
May inform shared decision-making on DBS battery type in PD; leaves open randomized trials on durability and costs.
Objective To evaluate the preference and satisfaction in the Chinese Parkinson’s disease (PD) patients treated with deep brain stimulation (DBS). Background DBS is a widely used therapy for PD. There is now a choice between fixed-life implantable pulse generators (IPGs) and rechargeable IPGs, each having their advantages and disadvantages. Methods Two hundred and twenty PD patients treated with DBS completed a self-designed questionnaire to assess long-term satisfaction and experience with the type of battery they had chosen, and the key factors affecting their choices. The survey was performed online and double-checked for completeness and accuracy. Results The median value of follow-up length was 18 months. 87.3% of the DBS used rechargeable IPGs (r-IPG). The choice between rechargeable and non-rechargeable IPGs was significantly associated with the patient’s affordability ( , p < 0.001). Interestingly, the feature of remote programming significantly affected patients’ choices between domestic and imported brands ( , p < 0.001). 87.7% of the patients were satisfied with the stimulating effects as well as the implanted device. 40.6% of the patients with r-IPGs felt confident handling their devices within one week after discharge. More than half of the patients checked their batteries every week. The mean interval for battery recharge was 4.3 days. 57.8% of the patients spent around one-hour recharging and 71.4% of them recharged the battery independently. The most popular way for patients to learn about DBS surgery was through media (79/220, 35.9%), including the Internet and television programs. The rehabilitation (40.6%, 78/192), and programming (36.5%, 70/192) were two main courses that most patients wanted to learn after surgery. Conclusion Most patients were satisfied with their choices of IPGs. The patients’ financial status and remote programming function were the two most critical factors in their decision. The skill of using rechargeable IPG was easy to master by most patients.
No takes yet. Share an insight, caveat, or question.
Qiu et al. (2020) conducted a cross-sectional in Parkinson's disease (n=220). Rechargeable implantable pulse generator (r-IPG) vs. Non-rechargeable implantable pulse generator (nr-IPG) was evaluated on Satisfaction with stimulating effects and implanted device (p=0.969). Satisfaction rates were high and comparable between Parkinson's disease patients using rechargeable (88.0%) and non-rechargeable (85.7%) deep brain stimulation batteries.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: